These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38143086)

  • 1. Epigenetic alterations of 11beta-hydroxysteroid dehydrogenase 1 gene in the adipose tissue of patients with primary aldosteronism.
    Takeda Y; Demura M; Kometani M; Karashima S; Aono D; Konishi S; Horike SI; Meguro-Horike M; Yoneda T; Takeda Y
    Endocr J; 2024 Mar; 71(3):245-252. PubMed ID: 38143086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of insulin sensitivity in adipose tissue of patients with primary aldosteronism.
    Urbanet R; Pilon C; Calcagno A; Peschechera A; Hubert EL; Giacchetti G; Gomez-Sanchez C; Mulatero P; Toffanin M; Sonino N; Zennaro MC; Giorgino F; Vettor R; Fallo F
    J Clin Endocrinol Metab; 2010 Aug; 95(8):4037-42. PubMed ID: 20484481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extra-adrenal regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1: physiological regulator and pharmacological target for energy partitioning.
    Walker BR
    Proc Nutr Soc; 2007 Feb; 66(1):1-8. PubMed ID: 17343766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In the lipodystrophy associated with highly active antiretroviral therapy, pseudo-Cushing's syndrome is associated with increased regeneration of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue.
    Sutinen J; Kannisto K; Korsheninnikova E; Nyman T; Ehrenborg E; Andrew R; Wake DJ; Hamsten A; Walker BR; Yki-Järvinen H
    Diabetologia; 2004 Oct; 47(10):1668-71. PubMed ID: 15455200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipose tissue 11beta-hydroxysteroid dehydrogenase type 1 expression in obesity and Cushing's syndrome.
    Mariniello B; Ronconi V; Rilli S; Bernante P; Boscaro M; Mantero F; Giacchetti G
    Eur J Endocrinol; 2006 Sep; 155(3):435-41. PubMed ID: 16914598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A calcium-deficient diet in pregnant, nursing rats induces hypomethylation of specific cytosines in the 11β-hydroxysteroid dehydrogenase-1 promoter in pup liver.
    Takaya J; Iharada A; Okihana H; Kaneko K
    Nutr Res; 2013 Nov; 33(11):961-70. PubMed ID: 24176236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor-alpha upregulates 11beta-hydroxysteroid dehydrogenase type 1 expression by CCAAT/enhancer binding protein-beta in HepG2 cells.
    Ignatova ID; Kostadinova RM; Goldring CE; Nawrocki AR; Frey FJ; Frey BM
    Am J Physiol Endocrinol Metab; 2009 Feb; 296(2):E367-77. PubMed ID: 19088256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 11beta-Hydroxysteroid dehydrogenase Type 1: genetic polymorphisms are associated with Type 2 diabetes in Pima Indians independently of obesity and expression in adipocyte and muscle.
    Nair S; Lee YH; Lindsay RS; Walker BR; Tataranni PA; Bogardus C; Baier LJ; Permana PA
    Diabetologia; 2004 Jun; 47(6):1088-95. PubMed ID: 15156315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A combination of polymorphisms in HSD11B1 associates with in vivo 11{beta}-HSD1 activity and metabolic syndrome in women with and without polycystic ovary syndrome.
    Gambineri A; Tomassoni F; Munarini A; Stimson RH; Mioni R; Pagotto U; Chapman KE; Andrew R; Mantovani V; Pasquali R; Walker BR
    Eur J Endocrinol; 2011 Aug; 165(2):283-92. PubMed ID: 21622477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and epigenetic analyses of aldosterone-producing adenoma with hypercortisolemia.
    Kometani M; Yoneda T; Demura M; Aono D; Gondoh Y; Karashima S; Nishimoto K; Yasuda M; Horike SI; Takeda Y
    Steroids; 2019 Nov; 151():108470. PubMed ID: 31400391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone stimulates adipose tissue 11beta-hydroxysteroid dehydrogenase type 1 expression in a depot-specific manner in children.
    Zhu L; Hou M; Sun B; Burén J; Zhang L; Yi J; Hernell O; Li X
    J Clin Endocrinol Metab; 2010 Jul; 95(7):3300-8. PubMed ID: 20410225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of 11β-hydroxysteroid dehydrogenase type 1 in visceral and subcutaneous adipose tissues of patients with polycystic ovary syndrome is associated with adiposity.
    Mlinar B; Marc J; Jensterle M; Bokal EV; Jerin A; Pfeifer M
    J Steroid Biochem Mol Biol; 2011 Feb; 123(3-5):127-32. PubMed ID: 21147223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 11beta-hydroxysteroid dehydrogenase type 1 and obesity.
    Morton NM; Seckl JR
    Front Horm Res; 2008; 36():146-164. PubMed ID: 18230901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone (GH) substitution in GH-deficient patients inhibits 11beta-hydroxysteroid dehydrogenase type 1 messenger ribonucleic acid expression in adipose tissue.
    Paulsen SK; Pedersen SB; Jørgensen JO; Fisker S; Christiansen JS; Flyvbjerg A; Richelsen B
    J Clin Endocrinol Metab; 2006 Mar; 91(3):1093-8. PubMed ID: 16368752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 11β-Hydroxysteroid dehydrogenase type 1: relevance of its modulation in the pathophysiology of obesity, the metabolic syndrome and type 2 diabetes mellitus.
    Pereira CD; Azevedo I; Monteiro R; Martins MJ
    Diabetes Obes Metab; 2012 Oct; 14(10):869-81. PubMed ID: 22321826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in hepatic and visceral adipose tissue is associated with metabolic disorders in morbidly obese patients.
    Baudrand R; Carvajal CA; Riquelme A; Morales M; Solis N; Pizarro M; Escalona A; Boza C; Pérez G; Domínguez A; Arrese M; Fardella CE
    Obes Surg; 2010 Jan; 20(1):77-83. PubMed ID: 19690925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue-specific dysregulation of 11β-hydroxysteroid dehydrogenase type 1 in overweight/obese women with polycystic ovary syndrome compared with weight-matched controls.
    Gambineri A; Fanelli F; Tomassoni F; Munarini A; Pagotto U; Andrew R; Walker BR; Pasquali R
    Eur J Endocrinol; 2014 Jul; 171(1):47-57. PubMed ID: 24743397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 activity in vivo limits glucocorticoid exposure to human adipose tissue and decreases lipolysis.
    Tomlinson JW; Sherlock M; Hughes B; Hughes SV; Kilvington F; Bartlett W; Courtney R; Rejto P; Carley W; Stewart PM
    J Clin Endocrinol Metab; 2007 Mar; 92(3):857-64. PubMed ID: 17200165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of cortisol producing adrenal adenoma without phenotype of Cushing's syndrome due to impaired 11beta-hydroxysteroid dehydrogenase 1 activity.
    Arai H; Kobayashi N; Nakatsuru Y; Masuzaki H; Nambu T; Takaya K; Yamanaka Y; Kondo E; Yamada G; Fujii T; Miura M; Komatsu Y; Kanamoto N; Ariyasu H; Moriyama K; Yasoda A; Nakao K
    Endocr J; 2008 Aug; 55(4):709-15. PubMed ID: 18493111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 11beta-hydroxysteroid dehydrogenase type 1 is overexpressed in subcutaneous adipose tissue of morbidly obese patients.
    Muñoz R; Carvajal C; Escalona A; Boza C; Pérez G; Ibáñez L; Fardella C
    Obes Surg; 2009 Jun; 19(6):764-70. PubMed ID: 18592327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.